Vaishali Pharma [VAISHALI] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Vaishali Pharma Ltd.

NSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vaishali Pharma Ltd. wins in 4 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vaishali Pharma Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 133.83 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 1.57 10.82 Vaishali Pharma Ltd.
Debt-to-Equity Ratio 23.15 0.58 Divi's Laboratories Ltd.
PEG Ratio N/A 4.63 N/A
EV/EBITDA -60.31 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) -0.45% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 5.81% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 5.81% 29.65% Divi's Laboratories Ltd.
Return on Equity 1.26% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 0.74% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-183.43M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -44.99% -0.43% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 0.92 16.18 Vaishali Pharma Ltd.
Enterprise Value $1.24B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.09 15.86 Vaishali Pharma Ltd.
Gross Profit Margin (TTM) 1.47% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $10 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $0.06 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) -0.01 0.19 Vaishali Pharma Ltd.

Vaishali Pharma Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

VAISHALI
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vaishali Pharma Ltd.0.42%-1.78%2.43%19.70%-10.93%-16.04%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vaishali Pharma Ltd.-44.99%-44.04%83.08%68.79%68.79%68.79%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Vaishali Pharma Ltd. vs Divi's Laboratories Ltd.

MetricVAISHALIDIVISLAB
Market Information
Market Cap i₹1.05B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i871,885253,443
90 Day Avg. Volume i455,768283,911
Last Close₹7.17₹6,608.50
52 Week Range₹4.75 - ₹13.59₹5,636.50 - ₹7,071.50
% from 52W High-47.24%-6.55%
All-Time High₹24.91 (Oct 14, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-71.22%-6.55%
Growth Metrics
Quarterly Revenue Growth-0.12%0.12%
Quarterly Earnings Growth-0.09%-0.01%
Financial Health
Profit Margin (TTM) i0.00%0.24%
Operating Margin (TTM) i0.06%0.30%
Return on Equity (TTM) i0.01%0.15%
Debt to Equity (MRQ) i23.150.58
Cash & Liquidity
Book Value per Share (MRQ)₹5.11₹580.95
Cash per Share (MRQ)₹0.08₹122.95
Operating Cash Flow (TTM) i₹-326,443,000₹19.67B
Levered Free Cash Flow (TTM) i₹8.17M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Vaishali Pharma Ltd. vs Divi's Laboratories Ltd.

MetricVAISHALI (Apr 26, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i133.8367.11
Forward P/E iN/A53.75
PEG Ratio iN/A4.63
Price to Sales (TTM) i0.9216.18
Price to Book (MRQ) i1.5710.82
Market Capitalization
Market Capitalization i₹1.05B₹1.69T
Enterprise Value i₹1.24B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.0915.86
Enterprise to EBITDA i-60.3148.63
Risk & Other Metrics
Beta i-0.010.19
Book Value per Share (MRQ) i₹5.11₹580.95

Financial Statements Comparison: Vaishali Pharma Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVAISHALI (2025)DIVISLAB (2025)
Revenue/Sales i978.82M93.25B
Cost of Goods Sold i856.75M38.70B
COGS % of Revenue i87.5%41.5%
Gross Profit i122.07M54.55B
Gross Margin i12.5%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i59.00M25.71B
Operating Margin i6.0%27.6%
EBITDA i93.22M33.19B
EBITDA Margin i9.5%35.6%
Pre-Tax Income i12.26M29.16B
Pre-Tax Income % of Revenue i1.3%31.3%
Income Tax i4.08M7.25B
Income Tax % of Revenue i0.4%7.8%
Net Income (Profit) i8.17M21.91B
Profit Margin i0.8%23.5%

Balance Sheet & Liquidity Metrics

MetricVAISHALI (2025)DIVISLAB (2025)
Cash & Equivalents i17.11M4.15B
Total Current Assets i1.04B100.81B
Total Current Assets % of Revenue i106.7%108.1%
Total Current Liabilities i400.53M14.52B
Total Current Liabilities % of Revenue i40.9%15.6%
Long-Term Debt i46.19M20.00M
Long-Term Debt % of Revenue i4.7%0.0%
Total Shareholders Equity i649.16M149.69B
Retained Earnings i157.29M134.00B
Retained Earnings % of Revenue i16.1%143.7%
Property, Plant & Equipment i03.19B

Cash Flow Statement Comparison

MetricVAISHALI (2025)DIVISLAB (2025)
Operating Cash Flow i-326.44M19.67B
Operating Cash Flow % of Revenue i-33.4%21.1%
Capital Expenditures i-3.05M-14.38B
Free Cash Flow i-183.43M2.15B
FCF Margin i-18.7%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVAISHALIDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i130.46M265.47M
Float Shares i68.14M117.72M
% Held by Insiders iN/A52.04%
% Held by Institutions iN/A28.65%
% Held by Public iN/A19.31%

Dividend Analysis & Yield Comparison: Vaishali Pharma Ltd. vs Divi's Laboratories Ltd.

MetricVAISHALIDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025